Skip to main content
Erschienen in: Modern Rheumatology 1/2008

01.02.2008 | Case Report

Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations

verfasst von: Tomoko Sugiura, Yasushi Kawaguchi, Satoru Fujikawa, Yukiko Hirano, Toru Igarashi, Manabu Kawamoto, Kae Takagi, Masako Hara, Naoyuki Kamatani

Erschienen in: Modern Rheumatology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

We report on three Japanese patients (two families) with familial Mediterranean fever (FMF), a rare disease in the Far East. Two of the patients (siblings with definite FMF) were heterozygous for both E148Q and M694I, and the remaining patient (with probable FMF and no family history of the disease) was heterozygous for both P369S and R408Q. Although the M694I mutation is less common among Mediterranean populations, it was present in 22 (76%) of 29 Japanese patients with FMF (previously reported cases). We therefore investigated the allele frequency of M694I in the healthy Japanese population, as well as other FMF-causing mutations in exon 10 (M680I, M694V, and V726A) and polymorphisms (E148Q, P369S, and R408Q) of the Mediterranean fever gene (MEFV). The allele frequencies of disease-causing mutations, even M694I, were <0.001. While those of E148Q, P369S, and R408Q were 0.23, 0.057, and 0.054, respectively. Because of the low allele frequencies of disease-causing mutations, FMF is an extremely rare disease among Japanese individuals. However, FMF is an important component of hereditary autoinflammatory syndrome, and a diagnosis of FMF is crucial for the choice of treatment, because of the benefit of colchicine therapy.
Literatur
1.
Zurück zum Zitat Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.PubMedCrossRef Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.PubMedCrossRef
2.
Zurück zum Zitat The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.CrossRef The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.CrossRef
3.
Zurück zum Zitat Tomiyama N, Oshiro S, Higashiuesato Y, et al. End-stage renal disease associated with familial Mediterranean fever. Intern Med. 2002;41:221–4.PubMedCrossRef Tomiyama N, Oshiro S, Higashiuesato Y, et al. End-stage renal disease associated with familial Mediterranean fever. Intern Med. 2002;41:221–4.PubMedCrossRef
4.
Zurück zum Zitat Yoshida K, Kanaoka S, Kajimura M, et al. A Japanese case of familial Mediterranean fever with family history demonstrating a mutation in MEFV. Intern Med. 2003;42:761–4.PubMedCrossRef Yoshida K, Kanaoka S, Kajimura M, et al. A Japanese case of familial Mediterranean fever with family history demonstrating a mutation in MEFV. Intern Med. 2003;42:761–4.PubMedCrossRef
5.
Zurück zum Zitat Kotone-Miyahara Y, Takaori-Kondo A, Fukunaga K, et al. E148Q/M694I mutation in 3 Japanese patients with familial Mediterranean fever. Int J Hematol 2004;79:235–7.PubMedCrossRef Kotone-Miyahara Y, Takaori-Kondo A, Fukunaga K, et al. E148Q/M694I mutation in 3 Japanese patients with familial Mediterranean fever. Int J Hematol 2004;79:235–7.PubMedCrossRef
6.
Zurück zum Zitat Nakamura A, Yazaki M, Tokuda T, Hattori T, Ikeda S. A Japanese patient with familial Mediterranean fever associated with compound heterozygosity for pyrin variant E148Q/M694I. Intern Med. 2005;44:261–5.PubMedCrossRef Nakamura A, Yazaki M, Tokuda T, Hattori T, Ikeda S. A Japanese patient with familial Mediterranean fever associated with compound heterozygosity for pyrin variant E148Q/M694I. Intern Med. 2005;44:261–5.PubMedCrossRef
7.
Zurück zum Zitat Kim S, Ikusaka M, Mikasa G, et al. Clinical study of 7 cases of familial Mediterranean fever with MEFV gene mutation. Intern Med. 2007;46:221–5.PubMedCrossRef Kim S, Ikusaka M, Mikasa G, et al. Clinical study of 7 cases of familial Mediterranean fever with MEFV gene mutation. Intern Med. 2007;46:221–5.PubMedCrossRef
8.
Zurück zum Zitat Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.PubMedCrossRef Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.PubMedCrossRef
9.
Zurück zum Zitat Booth DR, Gillmore JD, Lachmann HJ, et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM. 2000;93:217–21.PubMedCrossRef Booth DR, Gillmore JD, Lachmann HJ, et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM. 2000;93:217–21.PubMedCrossRef
10.
Zurück zum Zitat Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.PubMedCrossRef Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.PubMedCrossRef
11.
Zurück zum Zitat Tchernitchko DO, Gérard-Blanluet M, Legendre M, Cazeneuve C, Grateau G, Amselem S. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis. 2006;65:1154–7.PubMedCrossRef Tchernitchko DO, Gérard-Blanluet M, Legendre M, Cazeneuve C, Grateau G, Amselem S. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis. 2006;65:1154–7.PubMedCrossRef
12.
Zurück zum Zitat Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet. 2001;9:634–7.PubMedCrossRef Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet. 2001;9:634–7.PubMedCrossRef
13.
Zurück zum Zitat Cazeneuve C, Sarkisian T, Pêcheux C, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet. 1999;65:88–97.PubMedCrossRef Cazeneuve C, Sarkisian T, Pêcheux C, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet. 1999;65:88–97.PubMedCrossRef
14.
Zurück zum Zitat Chae JJ, Komarow HD, Cheng J, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591–604.PubMedCrossRef Chae JJ, Komarow HD, Cheng J, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591–604.PubMedCrossRef
15.
Zurück zum Zitat Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA. 2006;103:9982–7.PubMedCrossRef Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA. 2006;103:9982–7.PubMedCrossRef
16.
Zurück zum Zitat Majeed HA, EL-Shanti H, Al-Khateeb MS, Rabaiha ZA. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum. 2002;31:371–6.PubMedCrossRef Majeed HA, EL-Shanti H, Al-Khateeb MS, Rabaiha ZA. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum. 2002;31:371–6.PubMedCrossRef
17.
Zurück zum Zitat Pras E, Livneh A, Balow JE, et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998;75:216–9.PubMedCrossRef Pras E, Livneh A, Balow JE, et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998;75:216–9.PubMedCrossRef
18.
Zurück zum Zitat Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001–5.PubMedCrossRef Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001–5.PubMedCrossRef
Metadaten
Titel
Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations
verfasst von
Tomoko Sugiura
Yasushi Kawaguchi
Satoru Fujikawa
Yukiko Hirano
Toru Igarashi
Manabu Kawamoto
Kae Takagi
Masako Hara
Naoyuki Kamatani
Publikationsdatum
01.02.2008
Verlag
Springer Japan
Erschienen in
Modern Rheumatology / Ausgabe 1/2008
Print ISSN: 1439-7595
Elektronische ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-007-0003-2

Weitere Artikel der Ausgabe 1/2008

Modern Rheumatology 1/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.